Methods of inhibiting neutrophil recruitment to the gingival crevice
A neutrophil and protein technology, applied in non-central analgesics, pharmaceutical formulations, cosmetic preparations, etc., can solve the problem of destroying bones and tissues that support teeth
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0055] figure 1 Contains an illustration of the gingival crevasse model (GCM). GCM can be used to assess product health benefits in a cell culture model that closely mimics the gingival crevice. The crevasse is home to hundreds of bacterial species as well as gingival epithelial cells and neutrophils. Proteomics, bacterial effects and odor of secreted or expressed proteins can be evaluated and used to compare the effects of various compounds and compositions. GCM incorporates three components: neutrophil-like cells, biofilm containing oral bacteria, and oral epithelium.
[0056] Neutrophil-like cells: HL60 cells (ATCC #CCLO-240) can be induced to differentiate into a neutrophil-like cell type by exposing HL60 cells to retinoic acid. HL60 cells were maintained at 1x10 5 Cell density of cells / mL (medium for HL60IMEM ATCC#30-2005). Retinoic acid used to differentiate HL60 into neutrophil-like cells was prepared by dissolving retinoic acid in ETOH to generate a 1 mM ethanol s...
Embodiment 2
[0075] Oral compositions comprising arginine are disclosed in WO / 2011 / 123123, which corresponds to US 8,652,495, both of which are incorporated herein by reference. In some embodiments, an oral care composition comprises an orally acceptable vehicle; zinc oxide particles; and arginine. In some such embodiments, the zinc oxide particles have a median particle size of 1 micron to 7 microns; in some such embodiments, the zinc oxide particles have a particle size distribution of 3 microns to 4 microns, a particle size of 5 microns to 7 microns distribution, a particle size distribution of 3 microns to 5 microns, a particle size distribution of 2 microns to 5 microns, or a particle size distribution of 2 microns to 4 microns. In some of these various described embodiments, the zinc oxide particles are present in an amount of up to 5% by weight, such as 0.5% to 2% by weight, based on the total weight of the oral care composition. In some of these various described embodiments, the ...
Embodiment 3
[0077] Oral compositions comprising arginine are disclosed in WO 2014 / 088572, which corresponds to US 2015 / 0313813, both of which are incorporated herein by reference. In some embodiments, the oral care composition comprises: a source of zinc ions at about 0.05% to about 5% by weight; a source of fluoride ions in an amount effective to deliver fluoride from about 500 ppm to about 5,000 ppm; and about 0.1 % to about 10% by weight arginine. In some such embodiments, the source of zinc ions is selected from zinc citrate, zinc sulfate, zinc silicate, zinc lactate, zinc phosphate, zinc oxide, and combinations thereof, eg, in an amount effective to inhibit erosion. In some such embodiments, the oral composition is in the form of a dentifrice comprising abrasives. In some such embodiments, the amount of zinc is 0.5% to 4% by weight. In some such embodiments, the composition may also include one or more abrasives, one or more wetting agents, and one or more surfactants. In some suc...
PUM
Property | Measurement | Unit |
---|---|---|
particle size | aaaaa | aaaaa |
particle size | aaaaa | aaaaa |
particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com